• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.牛津-阿斯利康（ChAdOx1 nCoV-19）疫苗接种后出现的全身性大疱性固定性药疹。
Clin Exp Dermatol. 2022 Feb;47(2):428-432. doi: 10.1111/ced.14926. Epub 2021 Oct 10.
2
Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.与 COVID-19 疫苗接种相关的对称性药物相关性间擦疹和屈侧疹样发疹。
Clin Exp Dermatol. 2022 Jan;47(1):175-176. doi: 10.1111/ced.14898. Epub 2021 Aug 31.
3
De novo generalized pustular psoriasis following Oxford-AstraZeneca COVID-19 vaccine.接种牛津-阿斯利康新冠疫苗后新发泛发性脓疱型银屑病。
Clin Exp Dermatol. 2022 Jan;47(1):153-155. doi: 10.1111/ced.14895. Epub 2021 Sep 30.
4
Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19).1例接种基于腺病毒载体的COVID-19疫苗（ChAdOx1 nCov-19）后发生的全身性大疱性固定型药疹。
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e516-e517. doi: 10.1111/jdv.18059. Epub 2022 Mar 15.
5
Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients.牛津阿斯利康ChAdOx1-S新冠疫苗接种后复发的抗中性粒细胞胞浆抗体相关性血管炎：两例病例系列
Nephrology (Carlton). 2022 Jan;27(1):109-110. doi: 10.1111/nep.13993. Epub 2021 Nov 9.
6
Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.新型冠状病毒肺炎疫苗接种后严重单纯皮肤不良事件的表型谱：一项多中心病例系列研究及文献综述
Clin Exp Dermatol. 2022 Mar;47(3):614-616. doi: 10.1111/ced.15003. Epub 2021 Dec 16.
7
Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?接种第二剂AZD1222（牛津-阿斯利康）严重急性呼吸综合征冠状病毒2疫苗后发生的皮肤淋巴细胞性血管炎：是偶合还是因果关系？
Am J Dermatopathol. 2022 Jan 1;44(1):80-82. doi: 10.1097/DAD.0000000000002104.
8
Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.基于mRNA或腺病毒载体的SARS-CoV-2疫苗接种后亚急性皮肤型红斑狼疮的诱发和加重
Clin Exp Dermatol. 2022 Jan;47(1):161-163. doi: 10.1111/ced.14858. Epub 2021 Sep 13.
9
Unique Case of Urticarial Skin Eruptions After COVID-19 Vaccination.新冠疫苗接种后出现荨麻疹性皮疹的罕见病例。
Am J Dermatopathol. 2022 Mar 1;44(3):198-200. doi: 10.1097/DAD.0000000000002036.
10
Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.新型冠状病毒牛津阿斯利康疫苗接种后出现的大疱性斯威特综合征。
Br J Dermatol. 2022 Mar;186(3):e110. doi: 10.1111/bjd.20876. Epub 2021 Nov 24.

引用本文的文献

1
Fixed drug eruption after the Sinopharm COVID-19 vaccine.国药新冠疫苗接种后出现固定性药疹。
JEADV Clin Pract. 2022 Jun 29. doi: 10.1002/jvc2.40.
2
Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review.COVID-19 疫苗的水疱性和其他皮肤表现：范围界定和叙述性综述。
J Cutan Med Surg. 2023 May-Jun;27(3):260-270. doi: 10.1177/12034754231156561. Epub 2023 Feb 15.
3
Generalized fixed drug eruption following Pfizer-BioNtech COVID-19 vaccination.辉瑞-生物科技公司新冠疫苗接种后出现的全身性固定型药疹。
Clin Case Rep. 2022 Dec 8;10(12):e6684. doi: 10.1002/ccr3.6684. eCollection 2022 Dec.
4
A case of recurrent fixed drug eruption following the administration of 2 different coronavirus disease 2019 vaccines verified using intradermal and patch tests.1例在接种2种不同的2019冠状病毒病疫苗后出现复发性固定性药疹的病例，通过皮内试验和斑贴试验得以证实。
JAAD Case Rep. 2023 Mar;33:23-26. doi: 10.1016/j.jdcr.2022.08.029. Epub 2022 Aug 27.
5
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.新冠病毒疫苗接种后皮肤不良反应的全球流行率和临床表现：系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
6
Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from Brazil.ChAdOx1（牛津-阿斯利康）疫苗接种后的罕见皮肤反应：来自巴西的12例病例系列报道
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e601-e603. doi: 10.1111/jdv.18112. Epub 2022 Apr 12.
7
Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.接种 ChAdOx1 nCoV-19 疫苗后出现严重寻常型天疱疮：病例报告及文献复习
J Cosmet Dermatol. 2022 Jun;21(6):2311-2314. doi: 10.1111/jocd.14945. Epub 2022 Apr 9.
8
Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19).1例接种基于腺病毒载体的COVID-19疫苗（ChAdOx1 nCov-19）后发生的全身性大疱性固定型药疹。
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e516-e517. doi: 10.1111/jdv.18059. Epub 2022 Mar 15.

本文引用的文献

1
Bullous fixed drug eruption following administration of the recombinant adjuvant Shingrix vaccine.接种重组佐剂欣格来福疫苗后发生的水疱性固定药物疹。
BMJ Case Rep. 2021 Aug 19;14(8):e241293. doi: 10.1136/bcr-2020-241293.
2
Fixed drug eruption after pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and type b combined vaccine in an infant.一名婴儿接种五价白喉、破伤风、无细胞百日咳、灭活脊髓灰质炎病毒和 b 型流感嗜血杆菌联合疫苗后出现固定性药疹。
Eur J Hosp Pharm. 2023 Jul;30(4):e16. doi: 10.1136/ejhpharm-2021-002875. Epub 2021 Jul 7.
3
SARS-CoV-2 mRNA vaccine-associated fixed drug eruption.严重急性呼吸综合征冠状病毒2型信使核糖核酸疫苗相关的固定性药疹
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e560-e563. doi: 10.1111/jdv.17390. Epub 2021 Jun 11.
4
Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy.mRNA新冠疫苗接种后的皮肤不良反应：来自意大利东北部的早期报告。
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e548-e551. doi: 10.1111/jdv.17343. Epub 2021 Jun 7.
5
Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption.固定性药物疹：更新，强调潜在致命的全身性大疱性固定性药物疹。
Am J Clin Dermatol. 2020 Jun;21(3):393-399. doi: 10.1007/s40257-020-00505-3.

Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.

作者信息

Wantavornprasert K, Noppakun N, Klaewsongkram J, Rerknimitr P

机构信息

Division of Dermatology, Skin and Allergy Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Division of Allergy and Clinical Immunology, Skin and Allergy Research Unit, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

Clin Exp Dermatol. 2022 Feb;47(2):428-432. doi: 10.1111/ced.14926. Epub 2021 Oct 10.

DOI:10.1111/ced.14926
PMID:34482558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8652793/
Abstract
摘要